对使用麦角生物碱制剂治疗三个月的老年患者的脑电图和临床变化进行相关性研究。
Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.
作者信息
Matejcek M, Knor K, Piguet P V, Weil C
出版信息
J Am Geriatr Soc. 1979 May;27(5):198-202. doi: 10.1111/j.1532-5415.1979.tb06031.x.
Abstract
The results of a 3-month trial with an ergot alkaloid preparation (Hydergine) in 16 geriatric patients showed that, in accordance with a previously proposed working hypothesis, the improvement induced by the drug in electroencephalographic age-related changes was accompanied by clinical improvement in patients with similarly age-related mental deterioration.
摘要
对16名老年患者使用麦角生物碱制剂（喜得镇）进行的为期3个月的试验结果表明，根据先前提出的工作假设，该药物引起的脑电图年龄相关变化的改善伴随着年龄相关精神衰退患者的临床改善。
相似文献
1
Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.对使用麦角生物碱制剂治疗三个月的老年患者的脑电图和临床变化进行相关性研究。
J Am Geriatr Soc. 1979 May;27(5):198-202. doi: 10.1111/j.1532-5415.1979.tb06031.x.
2
Hydergine: a review of 26 clinical studies.喜得镇：26项临床研究综述。
Pharmakopsychiatr Neuropsychopharmakol. 1979 Nov;12(6):407-22. doi: 10.1055/s-0028-1094637.
3
An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature.一种麦角生物碱制剂（喜得镇）治疗痴呆症：临床文献的批判性综述
J Am Geriatr Soc. 1976 Nov;24(11):490-7. doi: 10.1111/j.1532-5415.1976.tb03271.x.
4
Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
J Am Geriatr Soc. 1984 Aug;32(8):584-8. doi: 10.1111/j.1532-5415.1984.tb06137.x.
5
[Long-term treatment of cerebrovascular changes in the elderly (author's transl)].
Dtsch Med Wochenschr. 1978 Mar 17;103(11):456-62. doi: 10.1055/s-0028-1104458.
6
[Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy].
Med Welt. 1982 Oct 22;33(42):1485-9.
7
Hydergine in senile mental impairment.喜得镇治疗老年精神障碍
Gerontology. 1982;28(1):54-74. doi: 10.1159/000212511.
8
Design aspects of clinical trials with ergot alkaloids: a comparison of two geriatric behavioral rating scales.
Adv Biochem Psychopharmacol. 1980;23:357-62.
9
Dihydroergotoxine: 6-mg versus 3-mg dosage in the treatment of senile dementia. Preliminary report.双氢麦角毒碱：6毫克与3毫克剂量治疗老年痴呆症的初步报告
J Am Geriatr Soc. 1979 Feb;27(2):80-2. doi: 10.1111/j.1532-5415.1979.tb03345.x.
10
Mental decline in the elderly: pharmacotherapy (ergot alkaloids versus papaverine).老年人的智力衰退：药物治疗（麦角生物碱与罂粟碱）。
J Am Geriatr Soc. 1975 Apr;23(4):169-74. doi: 10.1111/j.1532-5415.1975.tb00164.x.
引用本文的文献
1
Hydergine for dementia.喜得镇治疗痴呆症。
Cochrane Database Syst Rev. 2000;2000(2):CD000359. doi: 10.1002/14651858.CD000359.
2
'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.“脑活性”药物。临床药理学及在脑血管疾病中的治疗作用。
Drugs. 1983 Jul;26(1):44-69. doi: 10.2165/00003495-198326010-00003.
3
Co-dergocrine mesylate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in age-related cognitive decline.甲磺酸双氢麦角隐亭。其药效学、药代动力学特性及在年龄相关性认知功能减退中的治疗应用综述
Drugs Aging. 1992 May-Jun;2(3):153-73. doi: 10.2165/00002512-199202030-00002.
Zotero 插件